Skip to main content
SpringerLink
Log in

Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders: A Meta-Analysis

  • Correspondence
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Moteshafi H, Zhornitsky S, Brunelle S, et al. Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis. Drug Saf 2012; 35(10): 819–36

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA

    Ross J. Baldessarini

Authors
  1. Ross J. Baldessarini
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baldessarini, R.J. Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders: A Meta-Analysis. Drug Saf 35, 1183 (2012). https://doi.org/10.1007/BF03262003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03262003

Keywords

Search

Navigation